U.S. Metals and Mining Stock News

NasdaqGS:SIGI
NasdaqGS:SIGIInsurance

A Look At Selective Insurance Group (SIGI) Valuation After Q1 Earnings Dividends And Buyback Update

Selective Insurance Group (SIGI) is in focus after its first quarter update, which combined higher revenue with lower net income, along with fresh common and preferred dividends and a progress report on its ongoing share repurchase. See our latest analysis for Selective Insurance Group. The earnings release and dividend announcements appear to have coincided with a sharp pick up in sentiment, with a 14.64% 1 month share price return lifting year to date gains to 2.50%. However, the 1 year...
NasdaqCM:AHCO
NasdaqCM:AHCOHealthcare

Is It Time To Reassess AdaptHealth (AHCO) After A 60% One Year Rally?

If you are wondering whether AdaptHealth's current share price still offers value, it helps to step back and look at what recent performance and fundamentals are really saying. The stock closed at US$13.38, with returns of 10.1% over the last week, 19.5% over the last month, 38.4% year to date, and 59.9% over the past year. This puts recent price action firmly on investors' radar. These moves have come as AdaptHealth continues to attract attention within the healthcare sector, with investors...
NYSE:NRG
NYSE:NRGElectric Utilities

NRG Energy Debt Tender Reshapes Covenants And Investor Risk Profile

NRG Energy, through its Lightning Power subsidiary, has received over 99% early tenders in a cash offer for its 7.250% senior secured notes. The company also secured the required consents to amend the notes indenture, clearing the way to remove restrictive covenants and release certain guarantees and collateral. This debt move positions NRG to adjust its balance sheet structure and future obligations in a single, concentrated transaction. NRG Energy (NYSE:NRG), recently trading at about...
NYSE:AX
NYSE:AXBanks

Is It Too Late To Consider Axos Financial (AX) After Its Strong 1-Year Share Price Rally?

With Axos Financial trading at US$98.89, you might be asking whether the recent share price sits above, below, or roughly in line with what the business could be worth. The stock has returned 2.7% over the last 7 days, 19.2% over the past 30 days, 13.2% year to date and 54.7% over the last year, so price moves have been meaningful enough to make valuation a front of mind question. Alongside these returns, Axos Financial has been in the spotlight through ongoing coverage of its position in the...
NYSE:PRIM
NYSE:PRIMConstruction

Is It Too Late To Consider Primoris Services (PRIM) After Its Powerful Share Price Run?

Wondering if Primoris Services at around US$168.94 is still reasonably priced after such a strong run, or if you might be late to the story. The stock shows returns of 2.6% over 7 days, 17.7% over 30 days, 29.3% year to date and 176.4% over 1 year, with a very large 3 year return and 428.8% over 5 years that naturally raise questions about current value and risk. Recent coverage around Primoris Services has focused on its share price strength over multiple timeframes and what that could mean...
NasdaqGS:GSAT
NasdaqGS:GSATTelecom

Assessing Globalstar (GSAT) Valuation After Strong Momentum And Apple Partnership Narrative

What recent performance says about Globalstar (GSAT) With no single headline event in focus, Globalstar (GSAT) has still attracted attention after a roughly 31% return over the past month and about 26% over the past 3 months. See our latest analysis for Globalstar. Those short term share price gains sit on top of a very large 1 year total shareholder return, alongside multi year total shareholder returns that are also multiples of the initial investment. This signals strong momentum in how...
NasdaqGS:IMCR
NasdaqGS:IMCRBiotechs

How Investors Are Reacting To Immunocore (IMCR) Five-Year KIMMTRAK Survival Data In Uveal Melanoma

Immunocore Holdings plc recently reported five-year overall survival data for KIMMTRAK in unresectable or metastatic uveal melanoma, showing an OS rate of 16% versus 8% for investigator’s choice in the longest prospective Phase 3 randomized trial for this disease. These results also mark the longest follow-up yet reported for a T cell engager in a solid tumor, highlighting KIMMTRAK’s durable clinical impact in a setting with historically very poor long-term outcomes. We’ll now examine how...
NYSE:GMED
NYSE:GMEDMedical Equipment

Is It Time To Reassess Globus Medical (GMED) After Its Recent 1 Year Rally

Wondering if Globus Medical at around US$90.74 is priced for opportunity or already reflects the story? This article walks through the numbers so you can see how its current tag lines up with its fundamentals. The share price has moved by 3.9% year to date, with a 30 day return of 8.3% and a 1 year return of 25.5%, even after a recent 7 day decline of 3.3%. Recent coverage has focused on Globus Medical as a medical devices company in the healthcare sector and how its position in that space...
NYSE:ED
NYSE:EDIntegrated Utilities

Is Consolidated Edison (ED) Fairly Priced After Recent Share Price Stability?

Wondering if Consolidated Edison at around US$109.62 is offering fair value right now, or if the price is out of line with the fundamentals. The stock has returned 1.3% over the last 7 days, while the 30 day return is a 1.8% decline, set against a 9.6% return year to date and 1.0% over the past year. Recent coverage has focused on Consolidated Edison as a regulated utility with a long operating history and a role in essential power and gas infrastructure, which helps frame how investors...
NasdaqGS:DKNG
NasdaqGS:DKNGHospitality

Is It Time To Reconsider DraftKings (DKNG) After Recent Share Price Weakness?

If you are wondering whether DraftKings at around US$23.40 is priced for promise or already baking in a lot of optimism, the next sections will help you frame that question clearly. The stock has seen a 4.1% return over the past 7 days and 11.8% over the past 30 days, while year to date it sits at a 34.4% decline and a 29.7% decline over the last year. Recent attention on U.S. online sports betting and iGaming regulation, as well as ongoing discussion about market share among major...
NYSE:KO
NYSE:KOBeverage

Coca-Cola (KO) Net Margin Reaches 27.8% Reinforcing Profitability Focus In Q1 2026

Coca-Cola (KO) opened 2026 with Q1 revenue of US$12.5b and basic EPS of US$0.91, setting the tone for another data rich earnings season for the drinks giant. The company has seen quarterly revenue move from US$11.1b and EPS of US$0.77 in Q1 2025 to US$12.5b and EPS of US$0.91 in Q1 2026, while trailing twelve month EPS reached US$3.18, giving investors a clear view of consistent earnings delivery. With trailing net margins at 27.8% and earnings growth of 26% over the past year, this update...
NYSE:NATL
NYSE:NATLDiversified Financial

Do New ATM-as-a-Service Wins Quietly Strengthen NCR Atleos’ Recurring Revenue Story (NATL)?

NCR Atleos recently reported that Palmetto Citizens Federal Credit Union and Castle Leisure Limited have expanded and renewed ATM as a Service and Interactive Teller Machine agreements, deepening existing relationships across US credit unions and UK leisure venues. These renewed and expanded contracts highlight ongoing appetite for outsourced ATM operations and self-service enhancements, reinforcing demand for NCR Atleos’ managed services model. Next, we’ll explore how these expanded ATM as...
NYSE:AVB
NYSE:AVBResidential REITs

AvalonBay Communities Q1 FFO Softness Tests Bullish Narrative On Long Term Apartment Demand

AvalonBay Communities (AVB) has opened Q1 2026 with total revenue of US$770.1 million, basic EPS of US$2.33 and net income of US$325.7 million, alongside Funds From Operations of US$383.6 million that many investors track first for a residential REIT. The company has seen revenue move from US$744.9 million in Q1 2025 to US$770.1 million in Q1 2026, while trailing 12 month basic EPS stands at US$8.07 against revenue of about US$3.1 billion. This sets up a quarter where income metrics and...
NYSE:BXP
NYSE:BXPOffice REITs

A Look At BXP (BXP) Valuation After Strong Q1 Earnings And Major San Francisco Leasing Progress

BXP (BXP) is back in focus after first quarter results showed net income of US$101.58 million and earnings of US$0.64 per share, alongside fresh leasing activity in San Francisco’s South Financial District. See our latest analysis for BXP. BXP’s recent news comes after a mixed share price run, with a 15.03% 1 month share price return contrasting with a 12.77% year to date share price decline and a 36.64% 3 year total shareholder return. This suggests that momentum has recently picked up. If...
NYSE:ENR
NYSE:ENRHousehold Products

Is Energizer (ENR) Pricing Reflect Its 30 Day Rebound And Long Term Slide

If you are wondering whether Energizer Holdings at around US$19.69 is a bargain or a value trap, this breakdown will help you frame the price against what the business may be worth. The stock has been volatile, with a 15.8% gain over the last 30 days coming after a 23.4% decline over the past year and a 52.1% decline over five years. These moves can change how the market views both its potential and its risks. Recent coverage has largely focused on the share price slide over the past few...
NYSE:EPD
NYSE:EPDOil and Gas

Strait Of Hormuz Closure Tests Enterprise Products Partners Export Growth Story

Enterprise Products Partners (NYSE:EPD) reports record operating volumes linked to the ongoing closure of the Strait of Hormuz. The disruption to global energy flows is associated with a substantial boost to the company’s earnings and EBITDA in Q1 2026. Management outlines revised growth plans, capital allocation priorities, and the role of recently commissioned assets in responding to this supply shock. The company’s latest expansion projects influence expectations for North American energy...
NYSE:TT
NYSE:TTBuilding

Is Trane Technologies (TT) Still Attractive After Strong Multi Year Share Price Gains?

Considering whether Trane Technologies at around US$480 per share still offers value, or if most of the upside is already reflected in the price. The stock has been steady over the last week with a 0.3% return, while the 30 day, year to date, 1 year and 3 year returns of 17.2%, 20.8%, 37.3% and 163.7% provide a strong backdrop for any valuation check. Recent coverage has focused on Trane Technologies as a key player in building-related equipment and services, with attention on how its market...
NasdaqGS:TSAT
NasdaqGS:TSATTelecom

A Look At Telesat (NasdaqGS:TSAT) Valuation After Its Strong Recent Share Price Momentum

Why Telesat (TSAT) is back on investor radars Telesat (NasdaqGS:TSAT) has drawn fresh attention after a sharp move in its share price, with the stock showing a 36% gain over the past month and 52% over the past 3 months. See our latest analysis for Telesat. That recent surge sits within a much bigger move, with a year to date share price return of 56.93% and a 1 year total shareholder return of 195.80%. The 3 year total shareholder return is a very large multiple of the starting point,...
NYSE:NE
NYSE:NEEnergy Services

Assessing Noble (NE) Valuation After Q1 Results Dividend Reaffirmation And New US$565 Million Contracts

Noble (NE) shares are in focus after first quarter results combined higher net income with new contract awards of about US$565 million, a reaffirmed US$0.50 quarterly dividend, and maintained full year guidance. See our latest analysis for Noble. These earnings, contract wins and the reaffirmed dividend come after a strong run, with a 47.3% 90 day share price return and a 141.5% 1 year total shareholder return. This suggests momentum has been building despite a recent 4.9% 1 day pullback to...
NasdaqGS:ASTS
NasdaqGS:ASTSTelecom

AST SpaceMobile (ASTS) Valuation Check After FCC Approval For Expanded Satellite Constellation

AST SpaceMobile (ASTS) is back in focus after the Federal Communications Commission approved its request to modify authorization for the SpaceMobile non geostationary satellite system, clearing the way for up to 248 low Earth orbit satellites. See our latest analysis for AST SpaceMobile. Despite the FCC approval and a steady stream of launch related updates, the share price has recently pulled back, with a 1 day share price return of 6.89% decline and a 90 day share price return of 40.71%...
NYSE:GTY
NYSE:GTYRetail REITs

Is It Too Late To Consider Getty Realty (GTY) After Its Strong 1 Year Share Price Return?

If you are wondering whether Getty Realty's current share price still offers value or if most of the opportunity is already priced in, this breakdown focuses squarely on what you are paying for versus what you are getting. The stock closed at US$33.14, with a 30 day return of 4.4%, a 1 year return of 27.0% and a 5 year return of 40.3%, which will naturally shape how investors think about both upside potential and downside risk. Recent moves sit against a backdrop of ongoing interest in...
NYSE:OSK
NYSE:OSKMachinery

Oshkosh Defense Marine Solutions Spotlight Undervalued NYSE OSK Opportunity

Oshkosh Defense, a segment of NYSE:OSK, unveiled advanced military mobility solutions at Modern Day Marine 2026. The company highlighted new capabilities that support naval campaigns, including the ROGUE-Fires system and an enhanced Medium Tactical Vehicle Replacement (MTVR) 4x4. The event spotlighted Oshkosh Defense's focus on mobility and sustainment solutions for modern military requirements. For investors watching NYSE:OSK, this update sits at the core of Oshkosh's defense and specialty...
NasdaqGS:ERAS
NasdaqGS:ERASBiotechs

Erasca (ERAS) Valuation Check After Sharp Pullback And Premium Price To Book Ratio

Stock performance snapshot and trigger context Erasca (ERAS) has drawn attention after recent trading left the stock with a 1 day return of about 0.5% and a 7 day decline of roughly 0.5%, prompting a closer look at its clinical stage oncology profile. See our latest analysis for Erasca. The recent 1 day share price return of about negative 48% and 7 day share price return of roughly negative 54% sit against a much stronger year to date share price return of about 176% and a very large 1 year...
NasdaqCM:NNE
NasdaqCM:NNEElectrical

NANO Nuclear Faces New NRC Microreactor Rules For KRONOS Commercialization

US Nuclear Regulatory Commission finalized its technology inclusive Part 53 licensing rule, targeting advanced reactors. The NRC also proposed a new Part 57 framework focused on microreactor licensing. These actions directly affect the commercialization path for NANO Nuclear Energy's KRONOS MMR microreactor. The changes are relevant for investors watching regulatory risk and deployment timelines for NasdaqCM:NNE. NANO Nuclear Energy, listed as NasdaqCM:NNE, is working to bring its KRONOS...